Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|October 29, 2020
Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for TherapeuticsArshi Khanam, Shyam KottililFrontiers in Medicine|November 25, 2021
Acute-on-Chronic Liver Failure: Pathophysiological Mechanisms and ManagementArshi Khanam, Shyam KottililInternational Journal of Molecular Sciences|January 8, 2023
New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?Arshi Khanam, Shyam KottililScientific Reports|November 17, 2020
Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virusArshi Khanam, Shyamasundaran Kottilil, Eleanor WilsonMicroorganisms|November 27, 2024
Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative ReviewPoonam Mathur, Arshi Khanam, Shyam KottililCells|June 2, 2021
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?Arshi Khanam, Paul G Saleeb, Shyam KottililLiver International : Official Journal of the International Association for the Study of the Liver|December 4, 2018
Increased interleukin-23 receptor (IL-23R) expression is associated with disease severity in acute-on-chronic liver failureArshi Khanam, Nirupma Trehanpati, Shiv Kumar SarinInternational Journal of Molecular Sciences|June 2, 2021
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease ProgressionArshi Khanam, Joel V Chua, Shyam KottililHepatology (Baltimore, Md.)|October 24, 2021
Programmed death 1 expressing CD8<sup>+</sup> CXCR5<sup>+</sup> follicular T cells constitute effector rather than exhaustive phenotype in patients with chronic hepatitis BArshi Khanam, Lydia S Y Tang, Shyam KottililJournal of Translational Medicine|April 20, 2023
Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathwaysArshi Khanam, Alip Ghosh, Joel V Chua, et al.Pageof 3